Phase 3 Clinical Trials

Boston, USA & Shanghai, China – March 9, 2026 Rapport Therapeutics and Tenacia Biotechnology have announced a strategic collaboration...

North Chicago, Ill., September 26, 2025 – AbbVie (NYSE: ABBV) announced the submission of a New Drug Application (NDA)...